z-logo
open-access-imgOpen Access
HLA‐C *06:02 allele can influence clinical efficacy of certolizumab pegol?
Author(s) -
Dattola Annunziata,
Botti Elisabetta,
Galluzzo Marco,
Caposiena Dante Raffaele Caro,
Mazzilli Sara,
Campione Elena,
Melino Gennaro,
Candi Eleonora,
Bianchi Luca
Publication year - 2021
Publication title -
health science reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.462
H-Index - 7
ISSN - 2398-8835
DOI - 10.1002/hsr2.234
Subject(s) - medicine , psoriatic arthritis , certolizumab pegol , psoriasis , adalimumab , ustekinumab , human leukocyte antigen , genotyping , cohort , immunology , dermatology , disease , gastroenterology , genotype , antigen , biochemistry , chemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom